In addition, evaluating the cytokine expression during CIA, a strong upregulation of TGF-β1/2 in the disease remission state was demonstrated, suggesting that TGF-β could exert an anti-inflammatory regulation of T-cells in RA [149]. This evidence concerns the gene TGFB1 and rheumatoid arthritis.